首页> 外文会议>World biomaterials congress >Combination of low-temperature plasma processes in the design of a novel ampicillin-loaded surgical mesh for hernia repair
【24h】

Combination of low-temperature plasma processes in the design of a novel ampicillin-loaded surgical mesh for hernia repair

机译:结合低温等离子体工艺设计新型氨苄青霉素疝气修补手术网

获取原文

摘要

Introduction: One of the new trends in biomaterials research is to deliver active compounds locally in the surgical site from the medical device. One way to manage post-operatory infections associated with mesh implants in abdominal hernia repair surgery can be the loading of antibiotics to the surgical meshes. Plasma treatment of polymer fibers has been commonly employed to tailor surface adhesion and wetting properties by changing the surface chemical composition. Appropriate selection of the plasma source enables the introduction of diverse functional groups on the target surface to improve wettability, biocompatibility or to allow subsequent covalent immobilization or physical adsorption of various molecules such as dyestuffs, pharmaceutical or cosmetic active principles. Plasma can also be used for the deposition of polymer thin coatings by plasma polymerization process. By modifying the process parameters of the plasma and the precursor, different kinds of biocompatible coatings can be produced, from cell-adhesive to antifouling coatings. Materials and Methods: A polypropylene (PP) mesh was functionalized in air plasma at atmospheric pressure by corona plasma (380W. 1.9A, <7.0s), before its loading with ampicillin (AMP) from an aqueous solution. Plasma polymerization of the AMP-loaded mesh was performed (0.4mbar, 200W, 13.56MHz, 2h) with Ar carrier gas, using Tetraglyme as precursor to obtain a PEG-like thin coating of the mesh. Characterization techniques such as AFM, SEM, XPS, etc. were employed to determine the effect of plasma treatment on the surface topography and chemical composition. To evaluate the biological behavior of the modified meshes, in vitro assays regarding cell proliferation, morphology, viability, chemotaxis and cell adhesion were carried out on the materials using NIH-3T3 fibroblasts and THP1 monocytes. Antibacterial assays and in vitro release experiments of the AMP from the fiber to an isotonic liquid media were also carried out. Results and Discussion: Combination of plasma functionalization and polymerization in the design of this textile-based drug delivery system is fully justified by the distinct effects produced by these two plasma treatments. As a first-step in the design of the AMP-loaded mesh, plasma fundionalization of the polymer surface with polar O-groups was used to modify the PP fiber surface at nanometric level. Surface wettability was improved due to the increased availability of chemical bonds with the introduction of new C-O and COOH functional groups. This was employed for the subsequent attachment of AMP allowing an increase of its loading as function of the plasma treatment time. The chemical and morphological changes on the surface of PP fibers lead to a 3-fold improvement of the AMP loading in the meshes after only 3.5s of plasma treatment. However, this plasma treatment and the subsequent loading of AMP on the PP fibers were related with lower fibroblast adhesion, altered morphology and enhanced chemotaxis. Thus, plasma polymerization was used as dry method to create a thin coating of PEG with the aim of keeping the high antibiotic loadings obtained with plasma fundionalization and to maintain essentially unchanged fibroblast properties such as chemotaxis or adhesion with respect to untreated meshes, fulfilling the requirement of biocompatible device for the finished AMP-loaded mesh. Conclusions: Combination of plasma processes has been used to tailor the surface properties of PP meshes to obtain high loadings of AMP, maintaining the biological adhesion and the antibacterial activity of the current surgical meshes. Beyond the added value brought by the antibiotic loading of the mesh for its release directly to the surgical site, the use of plasma processes in the design of biomaterials brings an original approach to control simultaneously physical and chemical surface properties, but also regarding the treatment of the mesh without the use of any other chemicals for the binding of the active principle with the fiber.
机译:简介:生物材料研究的新趋势之一是从医疗器械在手术部位局部递送活性化合物。处理腹部疝修补手术中与网状植入物相关的术后感染的一种方法可以是向手术网中加载抗生素。聚合物纤维的等离子体处理已普遍用于通过改变表面化学组成来调整表面粘附性和润湿性。等离子体源的适当的选择使目标表面上引入不同的官能团,以提高润湿性,生物相容性或允许后续的共价固定化或各种分子如染料,药物或化妆品活性成分的物理吸附。等离子体也可以用于通过等离子体聚合工艺沉积聚合物薄涂层。通过修改等离子体和前驱物的工艺参数,可以生产从细胞粘合剂涂层到防污涂层的不同种类的生物相容性涂层。材料和方法:聚丙烯(PP)筛网在大气压下的空气等离子体中通过电晕等离子体(380W。1.9A,<7.0s)进行功能化,然后从水溶液中加载氨苄西林(AMP)。使用Tetraglyme作为前驱体,使用Ar载气对AMP加载的网孔进行等离子体聚合(0.4mbar,200W,13.56MHz,2h),以获得网状的PEG状薄涂层。采用诸如AFM,SEM,XPS等表征技术来确定等离子体处理对表面形貌和化学成分的影响。为了评估修饰网片的生物学行为,使用NIH-3T3成纤维细胞和THP1单核细胞对材料进行了有关细胞增殖,形态,生存力,趋化性和细胞粘附的体外测定。还进行了AMP从纤维到等渗液体介质的抗菌测定和体外释放实验。结果与讨论:这两种基于纺织品的药物递送系统在设计中将血浆功能化与聚合相结合,完全可以证明这两种血浆处理产生的独特效果。作为AMP加载网的设计的第一步,使用具有极性O基团的聚合物表面进行等离子基化处理,以纳米级改性PP纤维表面。由于引入了新的C-O和COOH官能团而增加了化学键的使用,因此提高了表面润湿性。它被用于随后的AMP附着,允许其负载随等离子处理时间的增加而增加。 PP纤维表面的化学和形态变化导致仅3.5秒的等离子处理后,网孔中AMP含量提高了3倍。然而,这种等离子体处理以及随后在PP纤维上的AMP负载与成纤维细胞粘附力降低,形态改变和趋化性增强有关。因此,等离子体聚合被用作干法以产生PEG的薄涂层,目的是保持通过血浆基化获得的高抗生素载量,并相对于未处理的网眼保持基本不变的成纤维细胞特性,例如趋化性或粘附性,从而满足要求用于完成AMP加载的网格的生物相容性设备的制造。结论:等离子体工艺的组合已被用于调整PP网的表面性能,以获得较高的AMP含量,并保持当前外科网的生物粘附性和抗菌活性。除了将网眼直接加载到外科手术部位而增加的抗生素负荷所带来的附加价值外,在生物材料设计中使用等离子工艺还提供了一种同时控制物理和化学表面特性的新颖方法,而且还涉及到对生物材料表面处理的控制。无需使用任何其他化学物质将网眼与纤维结合的有效成分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号